For the year ending 2025-12-31, CI made $274,900M in revenue. $5,957M in net income. Net profit margin of 2.17%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenues | 274,900 | 247,121 | 195,265 | 180,516 |
| Pharmacy and other service costs | 214,991 | 182,509 | 133,801 | 124,834 |
| Medical costs and other benefit expenses | 34,349 | 38,648 | 36,287 | 32,206 |
| Selling, general and administrative expenses | 14,617 | 14,844 | 14,822 | 13,186 |
| Amortization of acquired intangible assets | 1,743 | 1,703 | 1,819 | 1,876 |
| Total benefits and expenses | 265,700 | 237,704 | 186,729 | 172,102 |
| Income from operations | 9,200 | 9,417 | 8,536 | 8,414 |
| Interest expense and other | -1,408 | -1,435 | -1,446 | -1,228 |
| Debt extinguishment costs | - | - | 0 | 0 |
| Net gain (loss) on sale of businesses | 13 | 24 | -1,499 | 1,662 |
| Net realized investment (losses) gains | - | - | -78 | -495 |
| Net investment losses | -24 | -2,737 | - | - |
| Income before income taxes | 7,781 | 5,269 | 5,513 | 8,353 |
| Total income taxes | 1,493 | 1,491 | 141 | 1,607 |
| Net income | 6,288 | 3,778 | 5,372 | 6,746 |
| Less net income attributable to noncontrolling interests | 331 | 344 | 208 | 78 |
| Shareholders' net income | 5,957 | 3,434 | 5,164 | 6,668 |
| Basic EPS | 22.33 | 12.25 | 17.57 | 21.54 |
| Diluted EPS | 22.18 | 12.12 | 17.39 | 21.3 |
| Diluted Average Shares | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 |
Cigna Group (CI)
Cigna Group (CI)